Equity Analysis

Score Board

    Kabra Drugs Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524322
    INE323K01017
    10.5817271
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    25.04
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
As on: Feb 25, 2025 12:48 AM
Particulars
Company Name Kabra Drugs Ltd
Face Value 10
BSE Code 524322
Year End 202403
Full Year
Equity ( in Cr.) 23.71
B.V. 10.60
Sales in Cr. 0.00
NP in Cr. -0.74
NP Var% -118.00
Div% 0.00
CPS -0.30
EPS -0.30
Traded Value( in Lakhs) 0.02
52 Week High 11.00
52 Week Low 7.00
Price BSE 11.00
Price NSE 0.00
Market Capital( in Cr.) 25.04
P/C Ratio -35.40
P/E Ratio -35.40
Price Vs.BV 1.04
Latest Quarter
Year End 202412
Sales in Cr. 0.00
NP in Cr. -0.54
NP Var % -392.00
Trailing Twelve Months
Year End 202412
Sales 0.00
OPM 0.00
NP -1.85
NP Var% -264.39
EPS 0.00
PE 0.00